2010 BIOCOM Executive Committee:

Chair:

Dan Bradbury, Amylin Pharmaceuticals

Vice Chair:

M. Wainwright Fishburn, Jr., Cooley Godward Kronish LLP

Chair Elect:

Alex Lukianov, Nuvasive

Emeritus:

Randall E. Woods, Sequel Pharmaceuticals

Vice President and General Counsel:

Stephen Ferruolo, J.D., Ph.D., Goodwin Procter LLP

Vice President – Finance:

Theresa Drew, Deloitte

Vice President and Secretary:

Kennon W. Baldwin, Ferguson Pape Baldwin Architects

Vice President – Industry:

David Webb, Ph.D., Celgene

President and CEO:

Joseph D. Panetta, BIOCOM

Executive Committee:

Bernd Brust, Life Technologies
Scott Huennekens, Volcano Corporation
Jack Lief, Arena Pharmaceuticals, Inc.
David Marino, Irving Hughes
Magda Marquet, Ph.D., AltheaDx
Steven J. Mento, Ph.D., Conatus Pharmaceuticals, Inc.
Tina Nova, Genoptix
Trindl Reeves, Barney & Barney LLC
Larry Stambaugh, Apercu Consulting
Kleanthis G. Xanthopoulos, Ph.D., Regulus Therapeutics
Tony Yost, Novartis

Life Directors:

David Hale, Somaxon Pharmaceuticals
William Rastetter, Venrock Associates
Duane J. Roth, CONNECT